As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.
19 Analysts have issued a Galderma forecast:
19 Analysts have issued a Galderma forecast:
Jun '25 |
+/-
%
|
||
Revenue | 3,782 3,782 |
-
|
|
Gross Profit | 2,618 2,618 |
-
|
|
EBITDA | 858 858 |
-
|
EBIT (Operating Income) EBIT | 609 609 |
-
|
Net Profit | 305 305 |
-
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Head office | Switzerland |
CEO | Flemming Ørnskov |
Website | www.galderma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.